Get Even More Visitors To Your Blog, Upgrade To A Business Listing >>

Shareholding Changes and Insider Transactions: Implications for Enovis Co.’s Stock Value and Investor Confidence

On August 30, 2023, it was reported that the Swiss National Bank has reduced its Stake in Enovis Co. by 10.6% in the first quarter. According to the disclosure filed with the Securities and Exchange Commission (SEC), the institutional investor now owns 105,100 shares of Enovis stock after selling 12,500 shares during the period. At the end of the most recent quarter, Swiss National Bank’s ownership of Enovis was valued at $5,622,000, accounting for about 0.19% of the company’s total worth.

In addition to this development, it was noted that CFO Phillip Benjamin (Ben) Berry sold 645 shares of Enovis stock on June 2nd at an average price of $54.17 per share. This transaction amounted to a total value of $34,939.65. Following this sale, Berry’s direct ownership in the company now stands at 20,223 shares, which are valued at approximately $1,095,479.91.

The sale made by Berry was disclosed through a document filed with the SEC and can be accessed on its official website. It is interesting to note that over the last three months, insiders have sold a total of 886 shares of Enovis stock with a combined value of $49,613. This amounts to approximately 5.10% of the company’s current corporate insider ownership.

These recent developments related to shareholding changes within Enovis highlight significant activities in terms of ownership and transactions involving key stakeholders in the company. The Swiss National Bank’s decrease in its stake indicates a change in their investment strategy or risk management approach regarding their position in Enovis Co.

Moreover, CFO Phillip Benjamin Berry’s sale sheds light on his personal decision to divest some portion of his holdings in Enovis stock. Such transactions often prompt speculation about executives’ confidence in the company’s future performance or their need for liquidity.

Investors and market analysts will likely closely monitor these developments as they evaluate and assess Enovis Co.’s financial performance, corporate governance practices, and overall market sentiment. It remains to be seen how these ownership changes and insider transactions will impact Enovis’ stock value and investor confidence moving forward.

Enovis Corporation

ENOV

Neutral

Updated on: 30/08/2023

Financial Health

Weak


Debt to equity ratio: Neutral

Price to earnings ratio: Strong Sell

Price to book ratio: Buy

DCF: Strong Buy

ROE: Neutral

Show more

Price Target

Current $56.24

Concensus $67.00


Low $67.00

Median $67.00

High $67.00

Show more

Social Sentiments

We did not find social sentiment data for this stock

Analyst Ratings

Analyst / firm Rating
Vik Chopra
Wells Fargo
Buy
Show more

Enovis: Institutional Investors Increase Stake, Analysts Remain Bullish


Enovis, a leading company in the industry, has recently caught the attention of various institutional investors and hedge funds. These investors have made modifications to their holdings of Enovis, with some increasing their stake in the company.

For instance, the New Mexico Educational Retirement Board raised its stake in Enovis by 16.1% during the first quarter. They now own 8,633 shares of the company’s stock valued at $462,000 after acquiring an additional 1,200 shares in the last quarter. Similarly, Texas Permanent School Fund Corp raised its stake in Enovis by 33.6%, owning 42,733 shares valued at $2,286,000 after acquiring an additional 10,746 shares.

Another notable investor is Gamco Investors INC. ET AL, which raised its stake in Enovis by 3.2% during the fourth quarter. They now own 8,523 shares valued at $456,000 after acquiring an additional 266 shares. SummerHaven Investment Management LLC also increased its stake by 2.1% during the first quarter and now owns 14,680 shares valued at $785,000 after acquiring an additional 308 shares.

Furthermore,MQS Management LLC made a significant move by buying a new stake in Enovis during the first quarter worth approximately $236,000.The involvement of these institutional investors demonstrates confidence in Enovis’ potential to deliver positive returns.

When it comes to equities analysts’ perspective on Enovis stock,Few reports have been issued recently.Needham & Company LLC reissued a “buy” rating with a price objective of $70.00 on Enovis’ stock.Wells Fargo & Company also upgraded their rating from “equal weight” to “overweight” and lifted their price estimate from $55.00 to $67.00.Robert W.Baird also set an “outperform” rating and raised their price target from $67.00 to $70.00. It is notable that seven equities research analysts have rated the stock with a buy rating, according to Bloomberg.com.The consensus target price for Enovis is $65.29.

Examining Enovis’s key financial indicators, we see that on Wednesday, the company’s stock opened at $56.47.Enovis Co. has a 50-day simple moving average of $60.94 and a 200-day simple moving average of $57.79.The company’s 1-year low is $43.88 and its high point is $66.71.Enovis has a debt-to-equity ratio of 0.12, a current ratio of 2.51, and a quick ratio of 1.23.A deep dive into the numbers reveals that Enovis has a market cap of $3.08 billion and trades at a price-to-earnings ratio of -22.15.A beta value of 2.04 reflects the stock’s volatility in relation to the overall market.

Regarding Enovis’ most recent quarterly earnings report, released on August 3rd,the company reported earnings per share (EPS)of$0.61 for the quarter.This surpassed analysts’ consensus estimate by $0.08.Enovis achieved this positive result despite having a negative net margin of8.52%.Moreover,the company exhibited a positive return on equity of3.74%.In terms of revenue, Enovis recorded$428 million for the quarter, which exceeded analyst estimates of$420 million.Compared to the same quarter last year,the company experienced an impressive growth rate with its revenue increasing by8%.

Based on analysts’ expectations, it is predicted that Enovis Co.’s EPS for this year will be around2.
28.As we analyze these financial figures,it becomes evident that Enovis’ recent performance has been favorable, inspiring confidence among investors and analysts alike.

In conclusion, Enovis appears to be an exciting investment opportunity for various institutional investors and hedge funds. With several equities analysts recommending a “buy” rating and a consensus target price of $65.29, it is clear that there is significant optimism surrounding the company’s future prospects. Despite some fluctuations in its stock price, Enovis has consistently demonstrated its strength in the market, with solid financials and a positive growth trajectory. As investors continue to modify their holdings and increase their stake in Enovis, it is clear that they see long-term potential in this reputable company.

The post Shareholding Changes and Insider Transactions: Implications for Enovis Co.’s Stock Value and Investor Confidence appeared first on Best Stocks.



This post first appeared on Best Stocks, please read the originial post: here

Share the post

Shareholding Changes and Insider Transactions: Implications for Enovis Co.’s Stock Value and Investor Confidence

×

Subscribe to Best Stocks

Get updates delivered right to your inbox!

Thank you for your subscription

×